Dear Colleagues,

We cordially invite you to join us at the 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics (ECMC-P 2026), sponsored by MDPI’s open access journals Pharmaceuticals and Pharmaceutics.

This platform seeks to provide a forum for discussion for scientists from around the world to share recent developments and innovative ideas in medicinal chemistry and pharmaceutics. This will allow students, researchers, and experts to share their latest theories, results, models, and applications within this multidisciplinary area of knowledge. This is an entirely online conference that will be held in November at https://sciforum.net/event/ECMC-P2026. No registration fee will be charged to participants, and an added advantage is the lack of cost for flights, hotels, etc.

The conference will be organized around the aims and scope of the journals Pharmaceuticals and Pharmaceutics, which includes the following general topics:

S1. Invited Lectures;
S2. General;
S3. New Small Molecules as Drug Candidates;
S4. Natural Products and Biopharmaceuticals;
S5. Novel Methodologies and AI;
S6. New Modalities in Drug Discovery;
S7. Radiopharmaceuticals;
S8. Nanomedicine and Nanotechnology;
S9. Formulation, Drug Delivery, and Controlled Release;
S10. Biopharmaceutics, Disposition, Pharmacokinetics and Pharmacodynamics.

Researchers are invited to provide a short abstract (250 words maximum without figures and references) online, through this link from now until 10 September 2026.

Each participant can submit only one abstract as a presenting author and a maximum of three submissions per research group (each author can only sign a maximum of three contributions). An institutional email address is required to submit contributions. The authors will be notified in October 2026 about the acceptance status of their abstract(s). At that point, they will be asked to present their work (in English) as a poster, a slideshow, or a video using the templates provided by the conference (see Instructions for Authors). All accepted submissions will be displayed online and be open for discussion, comments, and questions during the entire conference at conference website on 1–30 November 2026.

All participants will be invited to submit a full paper describing their work. The papers will be peer-reviewed and, upon acceptance, published in the conference's Special Issue. A 20% discount on the article processing charge will be applied.

The scientific committee will select the most outstanding works, which will be rewarded with grants offered by the sponsoring journals, Pharmaceuticals and Pharmaceutics.

We look forward to engaging in exciting discussions and hearing new ideas and perspectives from experts in the field. All participants are welcome to join the online conference.

Kind regards,

Prof. Dr. Maria Emília Sousa—Interdisciplinary Centre of Marine and Environmental Research (CIIMAR) and University of Porto, Porto, Portugal
Prof. Mary J. Meegan—School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland
Dr. Alfredo Berzal-Herranz—Instituto de Parasitología y Biomedicina López-Neyra, (IPBLN-CSIC), Spain
Prof. Dr. Thierry Vandamme—Laboratory for the Conception and Application of Bioactive Molecules, Faculty of Pharmacy, University of Strasbourg, France
Prof. Dr. Francisco Javier Otero Espinar—Department of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Spain

Follow the conference organizer on Social Media

Sessions

Submission should be completed online by the authors by registering with https://sciforum.net/ and using the “Submit Abstract” function on the conference homepage.

- Scholars interested in participating in the conference can submit their abstract (250 words maximum without figures and without references) online at this website until 10 September 2026.
- Based on the submitted abstract, the conference committee will conduct a pre-evaluation of whether a contribution from the authors of the abstract will be welcome for The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics. All authors will be notified by 30 September 2026 with regard to the acceptance status of their abstract.
- If the abstract is accepted for this conference, the author will be invited to prepare a full description of their work in the form of a poster, slideshow, or video at their best convenience, until the submission deadline of 2 October 2026.
- Posters must be uploaded as a PDF file using the Poster template file available at the end of this section.
- Slideshows must be uploaded as a PDF file using the PPT template file available at the end of this section.
- Flash communications (5 minutes) and communications (10–20 minutes) must be uploaded as an mp4/.webm/.ogg (max size: 250Mb) file (video) using the PPT template file available at the end of this section.- Tips for authors: if you would like to prepare a video based on your PowerPoint presentation, you may use the "record slide" function in PowerPoint.

The presentation for accepted submission should be uploaded before 2 October 2026 via submission dashboard, for a final check and approval. Each work will be directed to the appropriate panel (posters, slideshows, flash communications, communications) by the conference organizing team.

- Length of the presentation: no more than 30 slides
- The slides should be in PDF format.
- Slide 1 (strictly one slide): Title, authors’ names, affiliation(s), email address of corresponding author, logos of the laboratory and/or institution (not mandatory).
- Slide 2 (strictly one slide): Graphical abstract; repeat the title of the presentation but avoid other text as far as possible.
- Slide 3 (strictly one slide): Abstract (max. 250 words) and 3–5 keywords, separated by semicolons.
- Slide 4 and following slides: These should contain (in the given sequence) Introduction, Results and Discussion, Conclusions.
- Last slide: Acknowledgments, and logos of sponsors (not mandatory).
- ECMC-P 2026 Slides Template should be used. And it will be added here soon.

Posters should be designed to allow independent understanding of the research and clearly present the essential elements of the study.

Each poster should include:

- Title, authors, affiliations, and contact details (clearly displayed at the top);
- Brief introduction outlining the research objective;
- Concise methodology summary;
- Main results, supported by clear, well-labeled figures or tables where appropriate;
- Short conclusion summarizing key findings and their relevance.

Technical specifications:
The poster should be in PDF format.
No copyright issues with any elements in the poster
Dimensions (cm): 84.1 × 118.9 (A0 - portrait)
Resolution:300 dpi
Pixel size (portrait, 300 dpi):9933 × 14043 px
Minimum font size:≥24

The poster template can be downloaded HERE. We will reach out to you closer to the dates of the conference with more information.

Note: The uploaded poster may be used as provided and serves as a reference. However, as long as the technical specifications are followed, scholars are welcome to use any poster template of their choice.

Flash communications (3–5 minutes) and communications (15 minutes maximum) must be uploaded as an mp4/.webm/.ogg (max size: 250Mb) file (video) using the PPT template file available at the end of this section.

- Communication (15 minutes maximum).
- Flash Communications (3–5 minutes).

After the event, the participants of ECMC-P 2026 will be able to download an electronic Certificate of Attendance by logging in to your Sciforum personal account. Once you are logged-in, go to your profile and click on 'My certificates'. A list of all Sciforum events you have attended is available and you simply have to click on "Download" next to the correct event.

It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.

MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.